Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Tesch

Showing results (11-20 of 171) with videos related to

Pageof 18
Sort By:
Leukemia & Lymphoma|May 27, 2004
Phase I/II clinical study of topotecan and cytarabine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia and acute myeloid leukemiaMartin R Weihrauch, Peter Staib, Bettina Seiberlich, et al.
Breast Care (Basel, Switzerland)|January 15, 2020
ACT-FASTER, a Prospective Cohort Study Exploring Treatment Patterns with Fulvestrant and Exemestane in Postmenopausal Patients with Advanced Hormone Receptor-Positive Breast Cancer under Real-Life Conditions in GermanyNicolai Maass, Helmut Ostermann, Kurt Possinger, et al.
Breast (Edinburgh, Scotland)|June 7, 2017
Palliative systemic therapy and overall survival of 1,395 patients with advanced breast cancer - Results from the prospective German TMK cohort studyThomas Fietz, Hans Tesch, Jacqueline Rauh, et al.
Clinical & Experimental Metastasis|December 25, 2002
Immunomagnetic enrichment and detection of isolated tumor cells in bone marrow of patients with epithelial malignanciesMartin R Weihrauch, Edmund Skibowski, Andreas Draube, et al.
Leukemia & Lymphoma|August 5, 2004
Repeated clonal relapses in classical Hodgkin's lymphoma and the occurrence of a clonally unrelated diffuse large B cell non-Hodgkin lymphoma in the same patientRoman K Thomas, Claudia Wickenhauser, Dieter Kube, et al.
International Journal of Cancer|December 4, 2004
The Epstein-Barr virus oncoprotein latent membrane protein 1 induces expression of the chemokine IP-10: importance of mRNA half-life regulationMartina Vockerodt, Diana Pinkert, Sigrun Smola-Hess, et al.
Breast Cancer (Tokyo, Japan)|December 6, 2017
Adjuvant chemotherapeutic treatment of 1650 patients with early breast cancer in routine care in Germany: data from the prospective TMK cohort studySteffen Dörfel, Claus-Christoph Steffens, Dirk Meyer, et al.
Acta Haematologica|July 31, 2022
Treatment-Free Remission in Real-World Chronic Myeloid Leukemia Patients: Insights from German Hematology PracticesJolanta Dengler, Hans Tesch, Kathleen Jentsch-Ullrich, et al.
Breast Cancer Research and Treatment|July 6, 2017
Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox projectHans-Jürgen Hurtz, Hans Tesch, Thomas Göhler, et al.
European Journal of Cancer (Oxford, England : 1990)|May 12, 2017
Treatment and pattern of bone metastases in 1094 patients with advanced breast cancer - Results from the prospective German Tumour Registry Breast Cancer cohort studyJan Schröder, Thomas Fietz, Andreas Köhler, et al.
Pageof 18

Showing results (11-20 of 171) with videos related to

Sort By:
Pageof 18
Leukemia & Lymphoma|May 27, 2004
Phase I/II clinical study of topotecan and cytarabine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia and acute myeloid leukemiaMartin R Weihrauch, Peter Staib, Bettina Seiberlich, et al.
Breast Care (Basel, Switzerland)|January 15, 2020
ACT-FASTER, a Prospective Cohort Study Exploring Treatment Patterns with Fulvestrant and Exemestane in Postmenopausal Patients with Advanced Hormone Receptor-Positive Breast Cancer under Real-Life Conditions in GermanyNicolai Maass, Helmut Ostermann, Kurt Possinger, et al.
Breast (Edinburgh, Scotland)|June 7, 2017
Palliative systemic therapy and overall survival of 1,395 patients with advanced breast cancer - Results from the prospective German TMK cohort studyThomas Fietz, Hans Tesch, Jacqueline Rauh, et al.
Clinical & Experimental Metastasis|December 25, 2002
Immunomagnetic enrichment and detection of isolated tumor cells in bone marrow of patients with epithelial malignanciesMartin R Weihrauch, Edmund Skibowski, Andreas Draube, et al.
Leukemia & Lymphoma|August 5, 2004
Repeated clonal relapses in classical Hodgkin's lymphoma and the occurrence of a clonally unrelated diffuse large B cell non-Hodgkin lymphoma in the same patientRoman K Thomas, Claudia Wickenhauser, Dieter Kube, et al.
International Journal of Cancer|December 4, 2004
The Epstein-Barr virus oncoprotein latent membrane protein 1 induces expression of the chemokine IP-10: importance of mRNA half-life regulationMartina Vockerodt, Diana Pinkert, Sigrun Smola-Hess, et al.
Breast Cancer (Tokyo, Japan)|December 6, 2017
Adjuvant chemotherapeutic treatment of 1650 patients with early breast cancer in routine care in Germany: data from the prospective TMK cohort studySteffen Dörfel, Claus-Christoph Steffens, Dirk Meyer, et al.
Acta Haematologica|July 31, 2022
Treatment-Free Remission in Real-World Chronic Myeloid Leukemia Patients: Insights from German Hematology PracticesJolanta Dengler, Hans Tesch, Kathleen Jentsch-Ullrich, et al.
Breast Cancer Research and Treatment|July 6, 2017
Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox projectHans-Jürgen Hurtz, Hans Tesch, Thomas Göhler, et al.
European Journal of Cancer (Oxford, England : 1990)|May 12, 2017
Treatment and pattern of bone metastases in 1094 patients with advanced breast cancer - Results from the prospective German Tumour Registry Breast Cancer cohort studyJan Schröder, Thomas Fietz, Andreas Köhler, et al.
Pageof 18